Concepedia
Statistics
Publications
72
Citations
6.1K
H-Index
35
Active since
1978
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
Sapporo Medical University
The University of Tokyo
Tokyo Women's Medical University
Hiroshi Yasui is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and multiple myeloma.
Publications per year
1978–2023
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
Dharminder Chauhan, Laurence Catley, Guilan Li et al. · Cancer Cell · 2005 · 698 citations · Full text
Medicine, Oncology, Pharmacology +14
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
Teru Hideshima, Laurence Catley, Hiroshi Yasui et al. · Blood · 2006 · 421 citations · Full text
Medicine, Oncology, Pharmacology +15
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application
Toshiaki Hayashi, Teru Hideshima, Masaharu Akiyama et al. · British Journal of Haematology · 2004 · 319 citations
Life Sciences, Immunology, Pharmacology +17
Bortezomib Mediates Antiangiogenesis in Multiple Myeloma via Direct and Indirect Effects on Endothelial Cells
Aldo M. Roccaro, Teru Hideshima, Noopur Raje et al. · Cancer Research · 2006 · 285 citations
Medicine, Oncology, Pharmacology +17
Nuclear Export of Glucocorticoid Receptor is Enhanced by c-Jun N-Terminal Kinase-Mediated Phosphorylation
Motoyuki Itoh, M Adachi, Hiroshi Yasui et al. · Molecular Endocrinology · 2002 · 237 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
1–5 of 72